This volume represents a compendium of scientific findings and approaches to the study of angiogenesis in cancer. The second edition of Antiangiogenic Agents in Cancer Therapy is intended to give a current perspective on the state-of-the-art of angiogenensis and therapy directed at this process.
Antiangiogenesis is a dynamic and evolving field in oncology. New therapeutic targets continue to emerge followed by the rapid development of new therapeutic agents to be investigated in clinical trials. Optimizing the therapeutic potential of antiangiogenic agents in combination with the other therapies in the armamentarium to fight cancer will be an on-going challenge.
Publisher: Humana Press Inc.
Number of pages: 559
Weight: 1234 g
Dimensions: 240 x 168 mm
Edition: Softcover reprint of the original 2nd ed. 200
From the reviews of the second edition:
"This is a second edition of a well-accepted text on angiogenesis and antiangiogenic agents, particularly on their use in cancer therapy. In addition to the editors, a large number of outstanding investigators have contributed to this book. ... This edition is highly recommended to all of those involved in research or the clinical practice of oncology." (Julian L. Ambrus and Clara M. Ambrus, The Journal of Medicine, March, 2008)
You may also be interested in...
Would you like to proceed to the App store to download the Waterstones App?
Please note that owing to current COVID-19 restrictions, many of our shops are closed. Find out more by clicking here.